De Santis D, Bishara A, Witt C S, Nagler A, Brautbar C, Slavin S, Christiansen F T
Department of Clinical Immunology and Biochemical Genetics, Royal Perth Hospital, Perth, Australia.
Tissue Antigens. 2005 Jun;65(6):519-28. doi: 10.1111/j.1399-0039.2005.00396.x.
Matching of donor and recipient for the class I human leukocyte antigen-C (HLA-C)-encoded natural killer (NK) epitopes has been reported to influence stem-cell (SC) graft outcome, but a consistent picture has not yet emerged. We have analyzed transplant outcome in 104 unrelated SC grafts in relation to NK epitope (C1 and C2) matching and donor killer cell immunoglobulin-like receptor (KIR) genotype. NK epitope mismatching in the rejection direction was strongly associated with an increased probability of rejection subsequent to engraftment. The prevalence of grades III-IV acute graft-vs-host disease (GVHD) was significantly higher and occurred significantly earlier when there was NK epitope mismatching in the GVH direction. Higher transplant-related mortality and lower disease-free survival rates were associated with epitope mismatching regardless of the mismatch direction. A greater number of KIR receptors, both activating and inhibitory, in the donor protected against grades III-IV GVHD and improved survival.
据报道,供体与受体在I类人类白细胞抗原C(HLA-C)编码的自然杀伤(NK)表位上的匹配会影响干细胞(SC)移植结果,但尚未形成一致的结论。我们分析了104例无关SC移植的移植结果,这些结果与NK表位(C1和C2)匹配情况以及供体杀伤细胞免疫球蛋白样受体(KIR)基因型有关。移植后排斥方向的NK表位错配与排斥概率增加密切相关。当移植物抗宿主病(GVHD)方向存在NK表位错配时,III-IV级急性GVHD的发生率显著更高,且发生时间显著更早。无论错配方向如何,表位错配都与更高的移植相关死亡率和更低的无病生存率相关。供体中更多数量的KIR受体,包括激活型和抑制型,可预防III-IV级GVHD并提高生存率。